eptides constitute an integral part of the MHC proteins without which these molecules aggregate and get degraded. The tertiary complex between peptide and ␣-and ␤-chains of the MHC is seen by the TCR as a single entity. The nature of a peptide modifies the complexes in such a way that the overall conformation of the MHC molecule is changed. The changes in conformation could be estimated by determination of SDS stability and hydrophobicity (1-5) and by mAb binding (6 -9).
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eptides constitute an integral part of the MHC proteins without which these molecules aggregate and get degraded. The tertiary complex between peptide and ␣-and ␤-chains of the MHC is seen by the TCR as a single entity. The nature of a peptide modifies the complexes in such a way that the overall conformation of the MHC molecule is changed. The changes in conformation could be estimated by determination of SDS stability and hydrophobicity (1) (2) (3) (4) (5) and by mAb binding (6 -9) .
MHC class II molecules are also critical for presentation of superantigens (Sag), 4 which are protein products of bacterial (b-Sag) or viral (v-Sag) origin. Sag are able to activate large numbers of T cells bearing TCR ␤-chains that interact with Sag-MHC class II complexes. For exogenous mouse mammary tumor virus (MMTV) the Sag presentation is an absolutely critical step in its life cycle (10, 11) . Cells of the immune system are the first targets of this virus (12) . The infected B cells present v-Sag in the context of MHC class II molecules to T cells, leading to stimulation and consequent proliferation of specific V␤-bearing T cells (13) . These events result in viral amplification and transport to the mammary glands. Without recognition of v-Sag by cognate T cells, there is no T cell activation, no infection of mammary epithelium, and no viral transmission to the progeny via milk (10, 11) . Sags that are present in the germline cause deletion of the Sag-reactive T cell subsets during formation of the immune repertoire (14) . The MHC class II isotype and allotype matters for v-Sag presentation: I-E molecules are more efficient than I-A (14) and among I-A allotypes there is a hierarchy of v-Sag presentation (14, 15) . As a result, mice lacking Sag-cognate T cells (10, 11) or animals with inappropriate MHC alleles (16) are either completely protected from, or are relatively resistant to, MMTV infection.
Whether v-Sag presentation by a given MHC molecule depends on the nature of a bound peptide was unknown. Targeted disruption of genes involved in MHC class II Ag presentation (DM, Refs. 17-19 and invariant chain (Ii), Ref. 20) , as well as generation of mice expressing single MHC-peptide complexes (21) , allowed the studies of the importance of the peptide repertoire limitation for T cell selection. Here, taking advantage of the array of animals with altered peptide presentation we address a specific question whether qualitative differences between MHC class II complexes affect presentation of v-Sag. RNase T 1 protection assays were performed as previously described (24), using BALBLA/(Mtv7)-specific probe (22) . RNA was isolated from milk of mice after the second pregnancy by the method of Chirgwin et al. (25) , and 5 g was used per assay. The same probe was used to test expression of Mtv7 in spleens. Forty micrograms of total RNA isolated from spleens was used for this analysis. X-ray film exposure was standard (12 h ) in all experiments.
Materials and Methods

Mice and approved symbols
CBA/J, CBA/CaJ, C57BL6/J (B6), 129/J, (B6 ϫ 129/J) F 1 , BALB/cJ, LP/J,
T cell activation
CD4
ϩ T cells were purified from lymph nodes by treatment with mAbs against MHC class II (Y3JP) (26) and 25-9-17 (27) , and anti-CD8 (53-6.72) (28) for 45 min at 4°C (10 7 cells per ml of culture supernatant) followed by negative selection with the mixture of magnetic beads (antimouse IgG, anti-mouse IgM, anti-rat IgG) from PerSeptive Biosystems (Framingham, MA) according to manufacturer's protocol. Sag-presenting cells were 2000 rad irradiated, T cell-depleted spleen cells (for b-Sag), or nonfractionated splenocytes (for v-Sag). For T cell depletion a mixture of anti-CD8 and anti-CD4 (GK1.5) (29) mAbs was used, followed by treatment with anti-rat Ig magnetic beads.
Proliferation of CD4 ϩ T cells in response to b-Sag was measured by 
Virus isolation
Milk collected from MMTV-free or MMTV-infected BALB/c mice was diluted 1:10 with PBS and centrifuged at 600 ϫ g for 15 min. Skim fraction of milk was centrifuged at 129,000 ϫ g for 1 h, and pellets containing viral particles were resuspended in PBS. Fifty microliters of the original milk volume was injected into footpads as previously described (22, 30) . After 4 days, cells from popliteal lymph nodes were stained with anti-CD4 and anti-V␤6 mAb and analyzed by FACS.
mAbs and FACS analysis
Anti-TCR V␤ mAbs coupled with FITC were obtained from PharMingen (San Diego, CA). Anti-CD4 mAbs coupled to PE were purchased from Sigma. FACS analysis was performed using a FACScan flow cytometer (Becton Dickinson, Mountain View, CA) and CellQuest software.
Results and Discussion
Lack of v-Sag presentation by DM KO cells
In DM KO mice most of class II molecules are occupied by class II binding Ii peptide. This complex alters recognition of A b by allogeneic T cells (17, 19) and affects T cell selection (31, 32 ) to DM KO males. TCR V␤ profile was analyzed in the N 2 generation of mice with or without Mtv7 and DM molecules. Deletion of T cells expressing cognate ␤-chains (V␤6) was used as a read-out. Should v-Sag be presented normally, the cognate T cells should be deleted. As expected all DM-sufficient Mtv7 ϩ N 2 mice have deleted V␤6 ϩ T cells (Fig.  1A) . In contrast, none of DM-negative Mtv7 ϩ mice showed deletion of Sag cognate T cells, even though expression of this provirus could be easily detected in the spleens of these mice by Mtv7-specific RNase T 1 protection assay (Fig. 1A) . We also tested the anti-v-Sag-specific response of DM KO mice to a mixture of exogenous MMTVs. Mice were injected with partially purified virus derived from BALB/cLA milk. BALB/cLA mice produce a complex of three viruses with V␤2-, V␤14-and V␤6-specific Sag, respectively (22, 23) . BALBLA virus encodes a Sag with the same V␤ specificity as Mtv7, capable of interacting with both I-E and I-A MHC class II molecules (22, 30) . A significant increase in the percentage of CD4 ϩ V␤6 ϩ T cells was detected in the regional lymph nodes of DM-sufficient mice injected into foot pads with virus-containing milk compared with control mice injected with MMTV-free milk (Fig. 1B) . In contrast, no T cell-specific stimulation was observed in DM KO mice injected with virus-containing milk (Fig. 1B) . These results indicated that APCs from DM KO mice failed to present exogenous and endogenous v-Sag.
T cells from DM KO mice are fully capable of recognizing a v-Sag
The lack of T cell deletion (Fig. 1A) or proliferation (Fig. 1B) in response to v-Sag could be explained by a lack of the proper thymic positive selection in DM KO mice. Thus, we tested the ability of T cells from DM KO mice to react to v-Sag presented by DMsufficient APC. To determine whether CD4 ϩ T cells from DM KO mice were able to recognize v-Sag, we tested their ability to increase the proportion of cells with appropriate TCR V␤-chains in response to an endogenous v-Sag in vitro. Purified CD4 ϩ T cells from DM KO and control B6 mice were cultured with irradiated splenocytes from Mtv7-positive D1.LP/J (H-2 b ) mice. T cells expressing several V␤s were expected to expand in reaction to Mtv7, including V␤6 ϩ T cells. After 3 days in culture the cells were stained with anti-V␤ mAbs. In two independent experiments, responding T cells have shown an increase in the percentage of V␤6 ϩ T cells after stimulation with Mtv7-expressing cells (Fig.  1C) . At the same time the numbers of noncognate V␤14 ϩ cells were not increased. In contrast, activation of the same cells with Mtv7-negative splenocytes from LP/J mice did not cause any special increase in V␤6 ϩ T cell subsets. The relatively small increase in CD4 ϩ V␤6 ϩ T cells from DM KO mice is most likely due to vigorous proliferation of T cells in response to MHC class II A b molecules. This is because A b -reactive cells are not deleted in DM KO mice (18, 31) . Thus, DM KO mice have T cells that can respond to the endogenous v-Sag. ϩ V␤6 ϩ T cells even though expression of the provirus could be easily detected in the spleens ( Fig. 2A) and in lymph nodes (data not shown) of these mice. Thus, like DM KO mice with limited MHC peptide repertoire, the A b Ep-transgenic animals expressing the single MHC class II-peptide complex were unable to present endogenous v-Sag to the T cells.
Lack of v-Sag presentation by A b E-transgenic APC
T cells from A b Ep mice are fully capable of recognizing a v-Sag
Next we sought to determine whether A b Ep-transgenic mice were able to generate CD4 ϩ T cells capable of v-Sag recognition. Purified CD4
ϩ from A b Ep-transgenic and control Ii KO mice were stimulated with Mtv7 ϩ/ϩ cells from D1.LP/J mice (Fig. 2B) . CD4 ϩ T cells from both A b Ep-transgenic and Ii KO mice recognized v-Sag as determined by their ability to increase the percent of V␤6 ϩ T cells after stimulation in vitro (Fig. 2B) . In contrast, activation with Mtv7 Ϫ/Ϫ LP/J cells did not show any increase in V␤6 ϩ subsets (Fig. 2B ). Although this increase was consistent in several experiments ( p ϭ 0.0015), it was very small. That relatively small increase was explained by a strong reactivity to A b molecules with various peptides (21) , which was obviously involving TCRs with diverse V␤-chain repertoire. To circumvent this problem we used a pair of allogeneic H-2 k strains CBA/J and CBA/CaJ, which are positive and negative for Mtv7, respectively. We expected that the frequency of cells responding to MHC class II H-2 k molecules would be lower and that we would be able to detect the anti-v-Sag response. In fact, in this case CD4 ϩ T cells isolated from A b Ep-transgenic mice responded to Mtv7 v-Sag by selective proliferation of the V␤6 ϩ cells, whereas proliferation to H-2 k molecules was nonselective in terms of V␤ usage ( 
Exogenous MMTV infection depends on diversity of peptides presented by MHC class II
MMTV life cycle is dependent on the v-Sag T cell activation, and viruses that lack Sag sequences cannot propagate in vivo (35) . Having established that peptides bound to MHC class II are important for presentation of endogenous MMTVs, we sought to determine whether exogenous MMTVs could infect MHC class II presentation mutants. Thus, we allowed DM KO and (B6 ϫ 129/ J)F 1 control females to ingest infected milk from BALB/cLA females and later analyzed their own milk for the presence of MMTVs. All three viruses could be readily detected in all milk samples of (B6 ϫ 129)F 1 females but not in DM KO mice (Fig.  3A , data for the most abundant LA virus is shown).
We then applied the same strategy for infection of Ii KO and A b Ep-transgenic mice. Ii KO and A b Ep animals were infected with LA viruses by foster-nursing on BALB/cLA females. The control Ii KO mice became infected and produced virus into the milk (Fig.  3B) . In contrast, there was no detectable virus in the milk of A b Eptransgenic mice exposed to MMTV (Fig. 3B) . Thus, even though T cells from mutant mice respond to v-Sag in vitro (Figs. 1C and  2 , B and C) they fail to do so in vivo due to a failure of Sag presentation leading to an aborted MMTV infection.
The failure to present v-Sag by mutant APC could not be attributed to the differences in the amount of MHC class II expressed on the cell surface. The total class II expression in the wild-type and DM KO mice is very similar (17-19) . The level of MHC class II in Ii KO and A b Ep-transgenic mice is below the levels of expression of MHC class II in the wild-type mice, but similar to each other (21) . In addition, the low total number of CD4 ϩ T cells in those mutants could not be at fault, because Ii KO mice have similar CD4
ϩ T cell numbers as DM KO mice (31) . However, the viral life cycle is complete in Ii KO mice but not in DM KO mice (Fig. 3) . Furthermore, CD4-negative mice that have very few functional non-CD8 ϩ T cells are susceptible to MMTV infection (36) . Moreover, mice that had over 90% of v-Sag-responding T cells deleted due to transgenic expression of a v-Sag (10) were producing detectable amounts of MMTV after two or more pregnancies (37) . Thus, even practically invisible populations of v-Sag-reactive T cells may promote MMTV infection. In our experiments, all MMTV-infected mice were analyzed after the second pregnancy, and none of the mutant mice became MMTV infected. Thus, qualitative differences between MHC class II complexes must be responsible for the observed differences in the v-Sag presentation.
Variable presentation of b-Sag by MHC class II-positive cells from mutant mice
The mode of v-Sag presentation by MHC class II molecules could be better understood if compared with the presentation of b-Sag by MHC class II-positive cells from wild-type and mutant mice. bSag vary in the manner they bind MHC class II molecules as demonstrated by analyses of Sag mutants and crystal structures of Sag-MHC complexes. For instance, staphylococcal enterotoxin (SE)A binds MHC class II at two sites (one on ␣-and one on ␤-chain) (38, 39) , and binding to His81␤ involves a Zn 2ϩ ion. Another b-Sag, SED also cross-links MHC class II molecules using Zn 2ϩ (40) . In contrast, SEB has a single MHC binding site and does not use Zn 2ϩ (41) (42) (43) (44) . Toxic shock syndrome toxin-1 (TSST-1) can bind Zn 2ϩ but does not require it to elicit T cell responses and uses a single site for binding MHC (45, 46) . Such differences in binding properties of b-Sag would likely be detected in MHC class II presentation mutants. Therefore, we compared b-Sag-dependent activation of normal CD4 ϩ T cells from B6 mice by T cell-depleted normal and mutant splenocytes. We readily observed the differences in proliferation of responding CD4 ϩ T cells (Fig. 4) . Some of our observations were in line with the previously published studies of b-Sag binding to MHC class II presentation mutants (31, 47) . However, to evaluate quantitatively the ability of mutants to present Sag, all of the mutants had to be compared in the same experiment. Although the range of protein concentrations that elicit maximal T cell activation varies for different b-Sag (nanogram range for TSST-1 and SEA, and 10 g range for SEB), the hierarchy of presentation of different b-Sag by the mutants can be found. Results of the experiments shown in Fig.  4 revealed the rank of presentation of the three tested b-Sag by wild-type and mutant APCs. It became clear that each Sag has its own pattern (Fig. 5) . For example, presentation of TSST-1 is weaker by Ii KO cells, but is much weaker by DM KO cells when compared with the wild-type cells. In contrast, SEA is presented relatively well by DM KO cells, but poorly by A b Ep-transgenic cells. Our data indicates that v-Sag presentation resembles (but is not identical to) the mode of presentation of TSST-1 than of other b-Sag tested, suggesting that these two Sag may favor similar MHC class II-peptide complexes for binding. Both SEA and TSST-1 have been previously shown to block the Mtv7 Sag-peptides binding to MHC class II in vitro. However, the concentrations of blocking b-Sag were 10 3 -10 4 times higher than required for T cell activation (48) . The similar mode of presentation such as of TSST-1 and v-Sag does not necessarily imply that the two types of Sag use exactly the same interaction sites on the MHC class II molecules (49) .
How do MHC class II variants affect Sag presentation? The most probable mechanism accounting for the Sag-presenting properties is the change in affinity of interaction between MHC class II molecule and Sag. Such differences have been shown to influence T cell activation quite dramatically; even a slight increase in MHC-Sag interaction could compensate for a huge loss of TCRSag interaction (50) .
b-Sag bind MHC on the cell surface and do not need any additional processing. Presentation of v-Sag has been more enigmatic since their discovery. MMTV Sag is believed to be a type II protein processed from a longer precursor (51, 52) . Recent compelling biochemical evidence suggests that v-Sag expression on the plasma membrane is independent of class II expression and that the Sag-MHC complexes are formed on the cell surface (53, 54) even in solution without any accessory proteins (55) . That is important, because different MHC-peptide complexes may have their own peculiarities of intracellular trafficking, which theoretically could affect the rate of v-Sag binding and presentation.
That MHC class II-bound peptides can influence the b-Sag presentation has been well documented (56 -58) , and MHC-binding residues within a peptide as well as the C terminus of the peptide have the most influence on b-Sag binding (58) . Two of MHC class II presentation mutants used in our study have peptide repertoire limited to either a single peptide (A b Ep) or to almost completely a single peptide (class II binding Ii peptide in DM KO mice). It is likely that peptides influence v-Sag binding indirectly by inducing MHC class II conformations that either do or do not favor v-Sag binding. However, the direct involvement of peptide residues in v-Sag binding cannot be excluded. Either way, the presentation of v-Sag (as well as the outcome of the retroviral infection) appears to be sensitive to the nature of the MHC-peptide complexes.
